Graduate Student Position Details
MRI biomarkers for Mild Cognitive Impairment and Alzheimer's Disease
Dr. Trevor Steve
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder with no known cure which will have an enormous impact on Canadian society in the next two decades. Biomarkers are playing an expanding role in the evaluation and approval of new disease-modifying agents for AD. However, existing biomarkers for AD have substantial limitations. Our lab is focused on the development and validation of novel MRI-based biomarkers for Alzheimer's disease progression.